Stereotactic radiotherapy for brain metastasisNoël, G.;Daisne, Jean-François;Thillays, F.(2012) Cancer radiothérapie — Vol. 16, p. S101-S110 (2012)
Filespdfdocument.pdf Restricted Access Adobe PDF421.59 KBNo accessDetailsAuthorsNoël, G.AuthorDaisne, Jean-FrançoisUCLouvainAuthorThillays, F.AuthorAbstractStereotactic radiosurgery is now well implanted in the radiotherapy treatment tools of brain metastasis. The dose can be delivered in one or multiple sessions. Results seem equivalent. CT scan and MRI imaging are required to delineate and calculate dosimetry. Doses are variable according to the size of the metastases, localization, pathology or equipment. Stabilization or reduction of tumour size is the rules after stereotactic treatment. Impact in terms of overall survival is more difficult to apprehend because of the general context of the disease. Many questions remain unresolved, such as the usefulness of whole brain irradiation, adaptation of the treatment schedule to tumour pathophysiology, role of stereotactic treatment after surgery of metastases, etc. © 2012 Société française de radiothérapie oncologique (SFRO).Show moreAffiliationsUCLouvain(MGD) Service d'oncologie médicaleShow moreCitations APA Chicago FWB Noël, G., Daisne, J.-F., & Thillays, F. (2012). Stereotactic radiotherapy for brain metastasis. Cancer radiothérapie, 16, S101-S110. https://doi.org/10.1016/j.canrad.2011.02.008 (Original work published 2012)